Table of Contents 1 Market Overview 1.1 Sorafenib Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Sorafenib Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 Patented Drugs 1.2.3 Generic Drugs 1.3 Market Analysis by Application 1.3.1 Overview: Global Sorafenib Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Kidney Cancer 1.3.3 Liver Cancer 1.3.4 Thyroid Cancer 1.3.5 Other 1.4 Overview of Global Sorafenib Market 1.4.1 Global Sorafenib Market Status and Outlook (2015-2025) 1.4.2 North America (United States, Canada and Mexico) 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy) 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.5 South America, Middle East & Africa 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Bayer 2.1.1 Bayer Details 2.1.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 Bayer SWOT Analysis 2.1.4 Bayer Product and Services 2.1.5 Bayer Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.2 Mylan 2.2.1 Mylan Details 2.2.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 Mylan SWOT Analysis 2.2.4 Mylan Product and Services 2.2.5 Mylan Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.3 Natco Pharma 2.3.1 Natco Pharma Details 2.3.2 Natco Pharma Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 Natco Pharma SWOT Analysis 2.3.4 Natco Pharma Product and Services 2.3.5 Natco Pharma Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.4 Cipla 2.4.1 Cipla Details 2.4.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 Cipla SWOT Analysis 2.4.4 Cipla Product and Services 2.4.5 Cipla Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 3 Sales, Revenue and Market Share by Manufacturer 3.1 Global Sorafenib Sales and Market Share by Manufacturer (2018-2019) 3.2 Global Sorafenib Revenue and Market Share by Manufacturer (2018-2019) 3.3 Market Concentration Rate 3.3.1 Top 3 Sorafenib Manufacturer Market Share in 2019 3.3.2 Top 6 Sorafenib Manufacturer Market Share in 2019 3.4 Market Competition Trend 4 Global Market Analysis by Regions 4.1 Global Sorafenib Sales, Revenue and Market Share by Regions 4.1.1 Global Sorafenib Sales and Market Share by Regions (2015-2020) 4.1.2 Global Sorafenib Revenue and Market Share by Regions (2015-2020) 4.2 North America Sorafenib Sales and Growth Rate (2015-2020) 4.3 Europe Sorafenib Sales and Growth Rate (2015-2020) 4.4 Asia-Pacific Sorafenib Sales and Growth Rate (2015-2020) 4.5 South America Sorafenib Sales and Growth Rate (2015-2020) 4.6 Middle East and Africa Sorafenib Sales and Growth Rate (2015-2020) 5 North America by Country 5.1 North America Sorafenib Sales, Revenue and Market Share by Country 5.1.1 North America Sorafenib Sales and Market Share by Country (2015-2020) 5.1.2 North America Sorafenib Revenue and Market Share by Country (2015-2020) 5.2 United States Sorafenib Sales and Growth Rate (2015-2020) 5.3 Canada Sorafenib Sales and Growth Rate (2015-2020) 5.4 Mexico Sorafenib Sales and Growth Rate (2015-2020) 6 Europe by Country 6.1 Europe Sorafenib Sales, Revenue and Market Share by Country 6.1.1 Europe Sorafenib Sales and Market Share by Country (2015-2020) 6.1.2 Europe Sorafenib Revenue and Market Share by Country (2015-2020) 6.2 Germany Sorafenib Sales and Growth Rate (2015-2020) 6.3 UK Sorafenib Sales and Growth Rate (2015-2020) 6.4 France Sorafenib Sales and Growth Rate (2015-2020) 6.5 Russia Sorafenib Sales and Growth Rate (2015-2020) 6.6 Italy Sorafenib Sales and Growth Rate (2015-2020) 7 Asia-Pacific by Regions 7.1 Asia-Pacific Sorafenib Sales, Revenue and Market Share by Regions 7.1.1 Asia-Pacific Sorafenib Sales and Market Share by Regions (2015-2020) 7.1.2 Asia-Pacific Sorafenib Revenue and Market Share by Regions (2015-2020) 7.2 China Sorafenib Sales and Growth Rate (2015-2020) 7.3 Japan Sorafenib Sales and Growth Rate (2015-2020) 7.4 Korea Sorafenib Sales and Growth Rate (2015-2020) 7.5 India Sorafenib Sales and Growth Rate (2015-2020) 7.6 Southeast Asia Sorafenib Sales and Growth Rate (2015-2020) 7.7 Australia Sorafenib Sales and Growth Rate (2015-2020) 8 South America by Country 8.1 South America Sorafenib Sales, Revenue and Market Share by Country 8.1.1 South America Sorafenib Sales and Market Share by Country (2015-2020) 8.1.2 South America Sorafenib Revenue and Market Share by Country (2015-2020) 8.2 Brazil Sorafenib Sales and Growth Rate (2015-2020) 8.3 Argentina Sorafenib Sales and Growth Rate (2015-2020) 9 Middle East & Africa by Countries 9.1 Middle East & Africa Sorafenib Sales, Revenue and Market Share by Country 9.1.1 Middle East & Africa Sorafenib Sales and Market Share by Country (2015-2020) 9.1.2 Middle East & Africa Sorafenib Revenue and Market Share by Country (2015-2020) 9.2 Saudi Arabia Sorafenib Sales and Growth Rate (2015-2020) 9.3 Turkey Sorafenib Sales and Growth Rate (2015-2020) 9.4 Egypt Sorafenib Sales and Growth Rate (2015-2020) 9.5 South Africa Sorafenib Sales and Growth Rate (2015-2020) 10 Market Segment by Type 10.1 Global Sorafenib Sales and Market Share by Type (2015-2020) 10.2 Global Sorafenib Revenue and Market Share by Type (2015-2020) 10.3 Global Sorafenib Price by Type (2015-2020) 11 Global Sorafenib Market Segment by Application 11.1 Global Sorafenib Sales Market Share by Application (2015-2020) 11.2 Global Sorafenib Revenue Market Share by Application (2015-2020) 11.3 Global Sorafenib Price by Application (2015-2020) 12 Market Forecast 12.1 Global Sorafenib Sales, Revenue and Growth Rate (2021-2025) 12.2 Sorafenib Market Forecast by Regions (2021-2025) 12.2.1 North America Sorafenib Market Forecast (2021-2025) 12.2.2 Europe Sorafenib Market Forecast (2021-2025) 12.2.3 Asia-Pacific Sorafenib Market Forecast (2021-2025) 12.2.4 South America Sorafenib Market Forecast (2021-2025) 12.2.5 Middle East & Africa Sorafenib Market Forecast (2021-2025) 12.3 Sorafenib Market Forecast by Type (2021-2025) 12.3.1 Global Sorafenib Sales Forecast by Type (2021-2025) 12.3.2 Global Sorafenib Market Share Forecast by Type (2021-2025) 12.4 Sorafenib Market Forecast by Application (2021-2025) 12.4.1 Global Sorafenib Sales Forecast by Application (2021-2025) 12.4.2 Global Sorafenib Market Share Forecast by Application (2021-2025) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source 15.3 Disclaimer 15.4 About US

List of Tables Table 1. Global Sorafenib Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Sorafenib by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Sorafenib Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Market Opportunities in Next Few Years Table 5. Market Risks Analysis Table 6. Market Drivers Table 7. Bayer Basic Information, Manufacturing Base and Competitors Table 8. Bayer Sorafenib Major Business Table 9. Bayer Sorafenib Total Revenue (USD Million) (2017-2018) Table 10. Bayer SWOT Analysis Table 11. Bayer Sorafenib Product and Services Table 12. Bayer Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 13. Mylan Basic Information, Manufacturing Base and Competitors Table 14. Mylan Sorafenib Major Business Table 15. Mylan Sorafenib Total Revenue (USD Million) (2017-2018) Table 16. Mylan SWOT Analysis Table 17. Mylan Sorafenib Product and Services Table 18. Mylan Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 19. Natco Pharma Basic Information, Manufacturing Base and Competitors Table 20. Natco Pharma Sorafenib Major Business Table 21. Natco Pharma Sorafenib Total Revenue (USD Million) (2017-2018) Table 22. Natco Pharma SWOT Analysis Table 23. Natco Pharma Sorafenib Product and Services Table 24. Natco Pharma Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 25. Cipla Basic Information, Manufacturing Base and Competitors Table 26. Cipla Sorafenib Major Business Table 27. Cipla Sorafenib Total Revenue (USD Million) (2017-2018) Table 28. Cipla SWOT Analysis Table 29. Cipla Sorafenib Product and Services Table 30. Cipla Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 31. Global Sorafenib Sales by Manufacturer (2018-2019) (K Units) Table 32. Global Sorafenib Revenue by Manufacturer (2018-2019) (USD Million) Table 33. Global Sorafenib Sales by Regions (2015-2020) (K Units) Table 34. Global Sorafenib Sales Market Share by Regions (2015-2020) Table 35. Global Sorafenib Revenue by Regions (2015-2020) (USD Million) Table 36. North America Sorafenib Sales by Countries (2015-2020) (K Units) Table 37. North America Sorafenib Sales Market Share by Countries (2015-2020) Table 38. North America Sorafenib Revenue by Countries (2015-2020) (USD Million) Table 39. North America Sorafenib Revenue Market Share by Countries (2015-2020) Table 40. Europe Sorafenib Sales by Countries (2015-2020) (K Units) Table 41. Europe Sorafenib Sales Market Share by Countries (2015-2020) Table 42. Europe Sorafenib Revenue by Countries (2015-2020) (USD Million) Table 43. Asia-Pacific Sorafenib Sales by Regions (2015-2020) (K Units) Table 44. Asia-Pacific Sorafenib Sales Market Share by Regions (2015-2020) Table 45. Asia-Pacific Sorafenib Revenue by Regions (2015-2020) (USD Million) Table 46. South America Sorafenib Sales by Countries (2015-2020) (K Units) Table 47. South America Sorafenib Sales Market Share by Countries (2015-2020) Table 48. South America Sorafenib Revenue by Countries (2015-2020) (USD Million) Table 49. South America Sorafenib Revenue Market Share by Countries (2015-2020) Table 50. Middle East & Africa Sorafenib Sales by Countries (2015-2020) (K Units) Table 51. Middle East & Africa Sorafenib Sales Market Share by Countries (2015-2020) Table 52. Middle East & Africa Sorafenib Revenue by Countries (2015-2020) (USD Million) Table 53. Middle East & Africa Sorafenib Revenue Market Share by Countries (2015-2020) Table 54. Global Sorafenib Sales by Type (2015-2020) (K Units) Table 55. Global Sorafenib Sales Share by Type (2015-2020) Table 56. Global Sorafenib Revenue by Type (2015-2020) (USD Million) Table 57. Global Sorafenib Revenue Share by Type (2015-2020) Table 58. Global Sorafenib Sales by Application (2015-2020) (K Units) Table 59. Global Sorafenib Sales Share by Application (2015-2020) Table 60. Global Sorafenib Sales Forecast by Regions (2021-2025) (K Units) Table 61. Global Sorafenib Market Share Forecast by Regions (2021-2025) Table 62. Global Sorafenib Sales Forecast by Type (2021-2025) (K Units) Table 63. Global Sorafenib Market Share Forecast by Type (2021-2025) Table 64. Global Sorafenib Sales Forecast by Application (2021-2025) Table 65. Global Sorafenib Market Share Forecast by Application (2021-2025) Table 66. Direct Channel Pros & Cons Table 67. Indirect Channel Pros & Cons Table 68. Distributors/Traders/ Dealers List List of Figures Figure 1. Sorafenib Picture Figure 2. Global Sales Market Share of Sorafenib by Type in 2019 Figure 3. Patented Drugs Picture Figure 4. Generic Drugs Picture Figure 5. Sorafenib Sales Market Share by Application in 2018 Figure 6. Kidney Cancer Picture Figure 7. Liver Cancer Picture Figure 8. Thyroid Cancer Picture Figure 9. Other Picture Figure 10. Global Sorafenib Market Status and Outlook (2015-2025) (USD Million) Figure 11. United States Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 12. Canada Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 13. Mexico Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 14. Germany Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 15. France Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 16. UK Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 17. Russia Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 18. Italy Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 19. China Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 20. Japan Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 21. Korea Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 22. India Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 23. Southeast Asia Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 24. Australia Sorafenib Revenue (Value) and Growth Rate (2015-2025) (USD Million) Figure 25. Brazil Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 26. Egypt Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 27. Saudi Arabia Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 28. South Africa Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 29. Turkey Sorafenib Revenue (Value) and Growth Rate (2015-2025) Figure 30. Global Sorafenib Sales Market Share by Manufacturer in 2019 Figure 31. Global Sorafenib Revenue Market Share by Manufacturer in 2019 Figure 32. Top 3 Sorafenib Manufacturer (Revenue) Market Share in 2019 Figure 33. Top 6 Sorafenib Manufacturer (Revenue) Market Share in 2019 Figure 34. Key Manufacturer Market Share Trend Figure 35. Global Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 36. Global Sorafenib Revenue and Growth Rate (2015-2020) (USD Million) Figure 37. Global Sorafenib Revenue Market Share by Regions (2015-2020) Figure 38. Global Sorafenib Revenue Market Share by Regions in 2018 Figure 39. North America Sorafenib Sales and Growth Rate (2015-2020) Figure 40. Europe Sorafenib Sales and Growth Rate (2015-2020) Figure 41. Asia-Pacific Sorafenib Sales and Growth Rate (2015-2020) Figure 42. South America Sorafenib Sales and Growth Rate (2015-2020) Figure 43. Middle East & Africa Sorafenib Sales and Growth Rate (2015-2020) Figure 44. North America Sorafenib Revenue and Growth Rate (2015-2020) (USD Million) Figure 45. North America Sorafenib Sales Market Share by Countries (2015-2020) Figure 46. North America Sorafenib Sales Market Share by Countries in 2018 Figure 47. North America Sorafenib Revenue Market Share by Countries (2015-2020) (USD Million) Figure 48. North America Sorafenib Revenue Market Share by Countries in 2018 Figure 49. United States Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 50. Canada Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 51. Mexico Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 52. Europe Sorafenib Revenue and Growth Rate (2015-2020) (USD Million) Figure 53. Europe Sorafenib Revenue Market Share by Countries (2015-2020) Figure 54. Europe Sorafenib Revenue Market Share by Countries in 2019 Figure 55. Germany Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 56. UK Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 57. France Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 58. Russia Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 59. Italy Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 60. Asia-Pacific Sorafenib Revenue and Growth Rate (2015-2020) (USD Million) Figure 61. Asia-Pacific Sorafenib Sales Market Share by Regions 2019 Figure 62. Asia-Pacific Sorafenib Revenue Market Share by Regions 2019 Figure 63. China Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 64. Japan Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 65. Korea Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 66. India Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 67. Southeast Asia Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 68. South America Sorafenib Revenue and Growth Rate (2015-2020) (USD Million) Figure 69. South America Sorafenib Sales Market Share by Countries in 2019 Figure 70. South America Sorafenib Revenue Market Share by Countries in 2019 Figure 71. Brazil Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 72. Argentina Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 73. Middle East and Africa Sorafenib Revenue and Growth Rate (2015-2020) (USD Million) Figure 74. Middle East and Africa Sorafenib Sales Market Share by Countries in 2019 Figure 75. Middle East and Africa Sorafenib Revenue Market Share by Countries (2015-2020) Figure 76. Middle East and Africa Sorafenib Revenue Market Share by Countries in 2019 Figure 77. Saudi Arabia Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 78. Egypt Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 79. Turkey Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 80. South Africa Sorafenib Sales and Growth Rate (2015-2020) (K Units) Figure 81. Global Sorafenib Sales and Growth Rate (2021-2025) (K Units) Figure 82. Global Sorafenib Revenue and Growth Rate (2021-2025) (USD Million) Figure 83. North America Sales Sorafenib Market Forecast (2021-2025) (K Units) Figure 84. Europe Sales Sorafenib Market Forecast (2021-2025) (K Units) Figure 85. Asia-Pacific Sales Sorafenib Market Forecast (2021-2025) (K Units) Figure 86. South America Sales Sorafenib Market Forecast (2021-2025) (K Units) Figure 87. Middle East & Africa Sales Sorafenib Market Forecast (2021-2025) (K Units) Figure 88. Sales Channel: Direct Channel vs Indirect Channel

Bayer Mylan Natco Pharma Cipla